These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27494627)

  • 1. Local tolerance testing under REACH: Accepted non-animal methods are not on equal footing with animal tests.
    Sauer UG; Hill EH; Curren RD; Raabe HA; Kolle SN; Teubner W; Mehling A; Landsiedel R
    Altern Lab Anim; 2016 Jul; 44(3):281-99. PubMed ID: 27494627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REACH and reproductive and developmental toxicology: still questions.
    Scialli AR; Guikema AJ
    Syst Biol Reprod Med; 2012 Feb; 58(1):63-9. PubMed ID: 22239083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro tests within the REACH information strategies.
    Louekari K; Sihvonen K; Kuittinen M; Sømnes V
    Altern Lab Anim; 2006 Aug; 34(4):377-86. PubMed ID: 16945005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated testing strategies for use with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():7-27. PubMed ID: 19025329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction to the EU REACH legislation.
    Grindon C; Combes R
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():1-6. PubMed ID: 19025328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical evaluation of the 2011 ECHA reports on compliance with the REACH and CLP regulations and on the use of alternatives to testing on animals for compliance with the REACH regulation.
    Spielmann H; Sauer UG; Mekenyan O
    Altern Lab Anim; 2011 Oct; 39(5):481-93. PubMed ID: 22103941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated decision-tree testing strategies for environmental toxicity with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():29-42. PubMed ID: 19025330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation.
    Höfer T; Gerner I; Gundert-Remy U; Liebsch M; Schulte A; Spielmann H; Vogel R; Wettig K
    Arch Toxicol; 2004 Oct; 78(10):549-64. PubMed ID: 15170526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated decision-tree testing strategy for eye irritation with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():111-22. PubMed ID: 19025335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction to the EU REACH legislation.
    Grindon C; Combes R
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():5-10. PubMed ID: 16555955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated testing strategy (ITS) for bioaccumulation assessment under REACH.
    Lombardo A; Roncaglioni A; Benfentati E; Nendza M; Segner H; Fernández A; Kühne R; Franco A; Pauné E; Schüürmann G
    Environ Int; 2014 Aug; 69():40-50. PubMed ID: 24806447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulatory acceptance of alternatives in the European Union.
    Warbrick EV; Evans PF
    Altern Lab Anim; 2004 Jun; 32 Suppl 1B():657-61. PubMed ID: 23581154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardisation of defined approaches for skin sensitisation testing to support regulatory use and international adoption: position of the International Cooperation on Alternative Test Methods.
    Casati S; Aschberger K; Barroso J; Casey W; Delgado I; Kim TS; Kleinstreuer N; Kojima H; Lee JK; Lowit A; Park HK; Régimbald-Krnel MJ; Strickland J; Whelan M; Yang Y; Zuang V
    Arch Toxicol; 2018 Feb; 92(2):611-617. PubMed ID: 29127450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin sensitisation--moving forward with non-animal testing strategies for regulatory purposes in the EU.
    Basketter D; Alépée N; Casati S; Crozier J; Eigler D; Griem P; Hubesch B; de Knecht J; Landsiedel R; Louekari K; Manou I; Maxwell G; Mehling A; Netzeva T; Petry T; Rossi LH
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):531-5. PubMed ID: 24140884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated decision-tree testing strategy for skin sensitisation with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():75-89. PubMed ID: 19025333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated decision-tree testing strategies for skin corrosion and irritation with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():65-74. PubMed ID: 19025332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals - a report by the transatlantic think tank for toxicology (t(4)).
    Rovida C; Hartung T
    ALTEX; 2009; 26(3):187-208. PubMed ID: 19907906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the status of alternative approaches to animal testing and the development of integrated testing strategies for assessing the toxicity of chemicals under REACH--a summary of a DEFRA-funded project conducted by Liverpool John Moores University and FRAME.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():149-58. PubMed ID: 16555968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated testing and intelligent assessment-new challenges under REACH.
    Ahlers J; Stock F; Werschkun B
    Environ Sci Pollut Res Int; 2008 Oct; 15(7):565-72. PubMed ID: 18818964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a tiered in vitro testing strategy for assessing the ocular and dermal irritation/corrosion potential of pharmaceutical compounds for worker safety.
    Graham JC; Wilt N; Costin GE; Villano C; Bader J; Krawiec L; Sly E; Gould J
    Cutan Ocul Toxicol; 2018 Dec; 37(4):380-390. PubMed ID: 30035615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.